Cytokines and the Brain: Implications for Clinical Psychiatry (original) (raw)

2000, American Journal of Psychiatry

Abstract

This article reviews recent developments in cytokine biology that are relevant to clinical psychiatry. Method: The authors reviewed Englishlanguage literature of the last 15 years that pertains to the biology of cytokines with emphasis on central nervous system effects in general and psychiatric disorders in particular.

Loading...

Loading Preview

Sorry, preview is currently unavailable. You can download the paper by clicking the button above.

References (102)

  1. Rothwell NJ (ed): Cytokine in the Nervous System. George- town, Tex, PG Landes, 1996
  2. Ransohoff RM, Benveniste EN (eds): Cytokines and the CNS. Boca Raton, Fla, CRC Press, 1996
  3. Plotnikoff N, Murgo A, Faith R, Good R (eds): Cytokines: Stress and Immunity. Boca Raton, Fla, CRC Press, 1999
  4. Kunkel SL, Remick DG (eds): Cytokines in Health and Disease. New York, Marcel Dekker, 1992
  5. Baggiolin M, Dewald B, Moser B: Human chemokines: an up- date. Annu Rev Immunol 1997; 15:675-705
  6. Licinio L, Kling M, Hauser P: Cytokines and brain function: relevance of interferon α-induced mood and cognitive changes. Semin Oncol 1998; 25:30-38
  7. Lin JS, Amaral TD, Brosnan CF, Lee SC: Interferons as critical regulators of IL-1 receptor antagonist and IL-1 expression in human microglia. J Immunol 1998; 16:1989-1996
  8. Breder CD, Tsujimoto M, Terano Y, Scott DW, Saper CB: Distri- bution and characterization of tumor necrosis factor-alpha- like immunoreactivity in the murine central nervous system. J Compr Neurol 1993; 337:543-567
  9. Bethea JR, Chung IY, Sparacio SM, Gillespie GY, Beneveniste EN: Interleukin-1β induction of tumor necrosis factor-alpha gene expression in human astroglioma cells. J Neuroimmu- nol 1992; 36:179-191
  10. Juul SE, Anderson DK, Li Y, Christensen RD: Erythropoietin and erythropoietin receptor in the developing human cen- tral nervous system. Pediatr Res 1998; 43:40-49
  11. Tweardy D, Mott P, Glazer E: Monokine modulation of hu- man astroglial cell production of granulocyte colony-stimu- lating factor and granulocyte-macrophage colony stimu- lating factor, I: effects of IL-1α and IL-1β. J Immunol 1990; 144:2233-2241
  12. Breder CD, Dinarello CA, Saper CB: Interleukin-1 immunore- active innervation of the human hypothalamus. Science 1988; 240:321-324
  13. Rothwell NJ, Luheshi G: Pharmacology of interleukin-1 ac- tions in the brain. Adv Pharmacol 1994; 25:1-20
  14. Hanisch UK, Quirion R: Interleukin-2 as a neuroregulatory cy- tokine. Brain Res Brain Res Rev 1995; 21:246-284
  15. Konishi Y, Chui DH, Kunishita T, Yamemura T, Higashi Y, Ta- bira T: Demonstration of interleukin-3 receptor-associated antigen on the central nervous system. J Neurosci Res 1995; 41:572-582
  16. Racke MK, Burnett D, Pak SH, Albert PS, Camella B, Raine CS, McFarlin DE, Scott DE: Retinoid treatment of experimental al- lergic encephalomyelitis: IL-4 production correlates with im- proved disease course. J Immunol 1995; 154:450-451
  17. Saweda N, Suzumura A, Itoh Y, Marunouchi T: Production of interleukin 5 by mouse astrocytes and microglia in culture. Neurosci Lett 1993; 155:175-178
  18. LeMay LB, Vander AJ, Kluger MJ: The effects of psychological stress on plasma interleukin-6 activity in rats. Physiol Behav 1990; 47:957-961
  19. Benveniste EN, Sparacia SM, Norris JG, Grenott HE, Muller GM: Induction and regulation of interleukin-6 gene expres- sion in rat astrocytes. J Neuroimmunol 1990; 30:201-212
  20. Ehrlich LC, Hu S, Sheng WS, Sutton RC, Rocks-Wolf GC, Peter- son PK, Chao CC: Cytokine regulation of human microglia cell IL-8 production. J Immunol 1998; 160:1944-1948
  21. Wong ML, Bongiorno PB, Rettori V, McCann SM, Licinio J: In- terleukin-1 beta, interleukin-1 receptor antagonist, IL-10 and IL-13 gene expression in the central nervous system and an- terior pituitary during systemic inflammation: pathophysio- logical implications. Proc Natl Acad Sci USA 1997; 94:227- 232
  22. Elenkov I, Papanicolaon D, Wilder R, Chrousos GP: Modula- tory effects of glucocorticoids and catecholamines on hu- man interleukin-12 and interleukin-10 production: clinical implications. Proc Assoc Am Physicians 1996; 108:334-381
  23. Stalder AK, Pagenstecher A, Yu NC, Kincaid C, Chiang CG, Hobbs MV, Bloom FE, Campbell IL: Lipopolysaccharide-in- duced IL-12 expression in the central nervous system and cultured astrocytes and microglia. J Immunol 1997; 159: 1344-1351
  24. Thompson A (ed): The Cytokine Handbook, 3rd ed. San Di- ego, Academic Press, 1998
  25. Mosmann TR, Coffman RL: TH1 and TH2 cells: different pat- terns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989; 7:145-173 ZIAD KRONFOL AND DANIEL G. REMICK
  26. Hurme M, Lahdenpohja N, Santtila S: Gene polymorphisms of interleukins 1 and 10 in infectious and autoimmune dis- eases. Ann Med 1998; 30:469-473
  27. Wilson AG, di Giovine FS, Duff GW: Genetics of tumour necro- sis factor alpha in autoimmune, infectious, and neoplastic diseases. J Inflamm 1995; 45:1-12
  28. Mira J-P, Cariou A, Grall F, Delclaux C, Losser M-R, Heshmati F, Cheal C, Monchi M, Teboul J-L, Riché F, Leleu G, Arbibe L, Mi- gnon A, Delpech M, Dhainaut J-F: Association of TNF2, a TNF- α promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study. JAMA 1999; 282:561-568
  29. Smeraldi E, Sanardi R, Benedetti F, DiBella D, Perez J, Catal- ano M: Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxa- mine. Mol Psychiatry 1998; 3:508-511
  30. Remick DG: Quantitation of cytokines, in Cytokines in Health and Disease, 2nd ed. Edited by Remick DG, Friedland JS. New York, Marcel Dekker, 1997, pp 281-298
  31. Cserr HF, Knopf PM: Cervical lymphatics, the blood-brain bar- rier and the immunoreactivity of the brain: a new view. Im- munol Today 1992; 13:507-512
  32. Watkins LR, Maier SF, Goehler LE: Cytokine-to-brain commu- nication: a review and analysis of alternative mechanisms. Life Sci 1995; 57:1011-1026
  33. Freidin M, Bennett MVL, Kessler JA: Cultured sympathetic neurons synthesize and release the cytokine interleukin-1β. Proc Natl Acad Sci USA 1992; 89:10440-10443
  34. Dinarello C: Interleukin-1, interleukin-1 receptors and inter- leukin-1 receptor antagonist. Int Rev Immunol 1988; 16: 457-499
  35. Weiss JM, Sundar SK, Becker KJ, Cierpial MA: Behavioral and neural influences on cellular immune responses: effects of stress and interleukin-1. J Clin Psychiatry 1989; 50:43-53
  36. Romero LI, Kakueska I, Lechan RM, Reichlin S: Interleukin-6 (IL-6) is secreted from the brain after intracerebroventricular injection of IL-1 beta in rats. Am J Physiol 1996; 270:R518- R524
  37. Giulian D, Woodward J, Young DG, Krebs JF, Lachman LB: In- terleukin-1 injected into mammalian brain stimulates astro- gliosis and neovascularization. J Neurosci 1988; 8:2485-2490
  38. Besedovsky H, del Rey A, Sorkin E, Da Prada M, Burri R, Honegger C: The immune response evokes changes in brain noradrenergic neurons. Science 1983; 221:564-566
  39. Dunn AJ, Powell ML, Meitin C, Small PA Jr: Virus infection as a stressor: influenza virus elevates plasma concentrations of corticosterone, and brain concentrations of MHPG and tryp- tophan. Physiol Behav 1989; 45:591-594
  40. Dunn AJ, Wang J: Cytokine effects on CNS biogenic amines. Neuroimmunomodulation 1995; 2:319-328
  41. Besedovsky H, Sorkin E, Keller M, Müller J: Changes in blood hormone levels during the immune response. Proc Soc Exp Biol Med 1975; 150:466-470
  42. Sapolsky R, Rivier C, Yamamoto G, Plotsky P, Vale WW: Inter- leukin-1 stimulates the secretion of hypothalamic corticotro- pin-releasing factor. Science 1987; 238:522-524
  43. Bernton EW, Beach JE, Holaday JW, Smallridge RC, Fein HGZ: Release of multiple hormones by a direct action of interleu- kin-1 on pituitary cells. Science 1987; 238:519-521
  44. Besedovsky H, del Rey A, Sorkin E, Da Prada M, Burri R, Honegger C: Cytokines as modulators of the hypothalamus- pituitary-adrenal axis. J Steroid Biochem Mol Biol 1991; 40: 613-618
  45. Rivier C: Neuroendocrine effects of cytokines in the rat. Rev Neurosci 1993; 4:223-237
  46. Rivest S, Rivier C: Centrally injected interleukin-1β inhibits the hypothalamic LHRH secretion and circulating LH levels via prostaglandins in rats. J Neuroendocrinol 1993; 5:445-450
  47. Krueger JM, Majde JA: Microbial products and cytokines in sleep and fever regulation. CRC Crit Rev Immunol 1994; 14: 355-379
  48. Moldofsky H, Lue FA, Eisen J, Keystone E, Gorczynski RM: The relationship of interleukin-1 and immune functions to sleep in humans. Psychosom Med 1986; 48:309-318
  49. Lue FA, Bail M, Jephthah-Ochola J, Carayanniotis K, Gorczyn- ski R, Moldofsky H: Sleep and cerebrospinal fluid interleukin- 1-like activity in the cat. Int J Neurosci 1988; 42:179-183
  50. Krueger JM: Somnogenic activity of immune response modi- fiers. Trends Pharmacol Sci 1990; 11:122-126
  51. Plata-Salaman CR, Sonti G, Borkoski JP, Wilson CD: Anorexia induced by chronic central administration of cytokines at es- timated pathophysiological concentrations. Physiol Behav 1996; 60:867-875
  52. Bessler H, Karp L, Notti I, Apter A, Tynus S, Djaldetti M, Weiz- man R: Cytokine production in anorexia nervosa. Clin Neu- ropharmacol 1993; 16:237-243
  53. Persoons JH, Schornagel K, Breve J, Berkenbosch F, Kraal G: Acute stress affects cytokines and nitric oxide production by alveolar macrophages differently. Am J Respir Crit Care Med 1995; 152:619-624
  54. Glaser R, Rice J, Speicher CE, Stout JC, Kiecolt-Glaser JK: Stress depresses interferon production by leukocytes concomitant with a decrease in NK cell activity. Behav Neurosci 1986; 100: 675-678
  55. Glaser R, Kennedy S, Lafuse WP, Bonneau RH, Speicher C, Hill- house J, Kiecolt-Glaser JK: Psychological stress-induced mod- ulation of interleukin 2 receptor gene expression and inter- leukin 2 production in peripheral blood leukocytes. Arch Gen Psychiatry 1990; 47:707-712
  56. Dobbin JP, Harth M, McCain GA, Martin RA, Cousin K: Cyto- kine production and lymphocyte transformation during stress. Brain Behav Immun 1991; 5:339-348
  57. Mittwoch-Jaffe T, Shalit F, Srendi B, Yehuda S: Modification of cytokine secretion following mild emotional stimuli. Neu- roreport 1995; 6:789-792
  58. Kiecolt-Glaser JK, Marucha PT, Malarkey WB, Mercado AM, Glaser R: Slowing of wound healing by psychological stress. Lancet 1995; 346:1194-1196
  59. Decker D, Schondorf M, Bidlingmaier F, Hirner A, von Ruecker AA: Surgical stress induces a shift in the type-1/type-2 T-helper cell balance, suggesting down-regulation of cell-mediated and up-regulation of antibody-mediated immunity commen- surate to the trauma. Surgery 1996; 119:316-325
  60. Nakano Y, Nakamura S, Hirata M, Harada K, Ando K, Tabuchi T, Matunaga I, Oda H: Immune function and lifestyle of taxi drivers in Japan. Ind Health 1998; 36:32-39
  61. Maes M, Song C, Lin A, De Jongh R, Van Gastel A, Kenis G, Bos- mans E, De Meester I, Benoy I, Neels H, Demedts P, Janca A, Scharpe S, Smith RS: The effects of psychological stress on humans: increased production of pro-inflammatory cytok- ines and a Th1-like response in stress-induced anxiety. Cytok- ine 1998; 10:313-318
  62. Ackerman KD, Martino M, Heyman R, Moyna NM, Rabin BS: Stressor-induced alteration of cytokine production in multi- ple sclerosis patients and controls. Psychosom Med 1998; 60: 484-491
  63. Marshall GD, Agarwal SK, Lloyd C, Cohen L, Henninger EM, Morris GJ: Cytokine dysregulation associated with exam stress in healthy medical students. Brain Behav Immun 1998; 12:297-307
  64. Glaser R, Kiecolt-Glaser JK, Marucha PT, MacCallum RC, Laskowski BF, Malarkey WB: Stress-related changes in proin- flammatory cytokine production in wounds. Arch Gen Psy- chiatry 1999; 56:450-456
  65. Maes M, Bosmans E, Meltzer HY, Scharpé S, Suy E: Interleu- kin-1β: a putative mediator of HPA axis hyperactivity in ma- jor depression? Am J Psychiatry 1993; 150:1189-1193
  66. Maes M, Meltzer H, Bosmans E, Bergmans R, Vandoolaeghe E, Rajan R, Desnyder R: Increased plasma concentrations of interleukin-6, soluble interleukin-6 receptor, soluble interleu- kin-2 receptor and transferrin receptor in major depression. J Affect Disord 1995; 34:301-309
  67. Weizman R, Laor N, Podliszewski E, Notti I, Djaldetti M, Bessler H: Cytokine production in major depressed patients before and after clomipramine treatment. Biol Psychiatry 1994; 35:42-47
  68. Kronfol Z, Singh VJ, Zhang Q: Plasma cytokines, acute phase proteins and cortisol in major depression (abstract). Biol Psy- chiatry 1995; 37(suppl):609A
  69. Kronfol Z, House JD: Lymphocyte mitogenesis, immunoglob- ulin and complement levels in depressed patients and nor- mal controls. Acta Psychiatr Scand 1989; 80:142-167
  70. Maes M, Smith RS: Fatty acids, cytokines, and major depres- sion. Biol Psychiatry 1998; 43:313-314
  71. Ganguli R, Rabin BS, Kelly RH, Lyte M, Ragu U: Clinical and laboratory evidence of autoimmunity in acute schizophre- nia. Ann NY Acad Sci 1987; 496:676-685
  72. Villemain F, Chatenoud L, Galinowski A, Homo-Delarche F, Ginestet D, Loo H, Zarifian E, Bach J-F: Aberrant T-cell-medi- ated immunity in untreated schizophrenic patients: deficient interleukin-2 production. Am J Psychiatry 1989; 146:609-616
  73. Ganguli R, Brar JS, Chengappa KR, Deleo M, Yang ZW: Mitogen- stimulated interleukin 2 production in never-medicated first episode schizophrenics-the influence of age of onset and negative symptoms. Arch Gen Psychiatry 1995; 52:668-672
  74. Rapaport MH, Torrey EF, McAllister CG, Nelson DL, Pickar D, Paul SM: Increased serum soluble interleukin-2 receptors in schizophrenic monozygotic twins. Eur Arch Psychiatr Clin Neurosci 1993; 243:7-10
  75. Ganguli R, Young Z, Shurin G, Chengappa KN, Brar JS, Gubbi AV, Rabin BS: Serum interleukin-6 concentration in schizo- phrenia: elevation associated with duration of illness. Psychi- atr Res 1994; 51:1-10
  76. Aisen PS, Davis KL: Inflammatory mechanisms in Alzheimer's disease: implications for therapy. Am J Psychiatry 1994; 151: 1105-1113
  77. Matsubara E, Hirrai S, Amari M, Shoji M, Yamaguchi H, Oko- moto K, Ishiguro K, Harigaya Y, Wakabayashi K: Alpha-1-anti- chymotripsin as a possible biochemical marker for Alzhei- mer-type dementia. Ann Neurol 1990; 28:561-567
  78. Abraham CR, Selkor DJ, Potter H: Immunohistochemical identification of the serum protein inhibitor alpha-1 antichy- motripsin in the brain amyloid deposits of Alzheimer's dis- ease. Cell 1988; 52:487-501
  79. Griffin WS, Stanley LC, Ling C, White L, MacLeod V, Perrot LJ, White CL III, Araoz C: Brain interleukin 1 and S-100 immu- noreactivity are elevated in Down syndrome and Alzheimer disease. Proc Natl Acad Sci USA 1989; 86:7611-7615
  80. Bauer J, Gauter U, Strauss S, Stadtmuller G, Frommberger U, Bauer H, Volk B, Berger M: The participation of interleukin-6 in the pathogenesis of Alzheimer's disease. Res Immunol 1992; 143:650-657
  81. Altstiel L, Sperber K: Cytokines in Alzheimer's disease. Prog Neuropychopharmacol Biol Psychiatry 1991; 15:481-495
  82. Brambilla F, Bellodi L, Perna G, Bertani A, Panerai A, Sacer- dote P: Plasma interleukin-1β concentrations in panic disor- der. Psychiatry Res 1994; 54:135-142
  83. Brambilla F, Perna G, Bellodi L, Arancio C, Bertani A, Perini G, Carraro C, Gava F: Plasma interleukin-1β and tumor necrosis factor concentrations in obsessive-compulsive disorders. Biol Psychiatry 1997; 42:976-981
  84. Warren RP: An immunologic theory for the development of some cases of autism. CNS Spectrums 1998; 3:71-79
  85. Dusheiko G: Side effects of alpha interferon in chronic hepa- titis C. Hepatology 1997; 26:1125-1215
  86. Schiller JH, Storer BE, Witt PL, Alberti D, Tombes MB, Arzooma- nian R, Proctor RA, McCarthy D, Brown RR, Voss SD, Remick SC, Grem JL, Borden EC, Trump DL: Biological and clinical effects of intravenous tumor necrosis factor-alpha administered three times weekly. Cancer Res 1991; 51:1651-1658
  87. Rosenberg SA: The development of new immunotherapies for the treatment of cancer using interleukin-2: a review. Ann Surg 1988; 208:121-135
  88. Renault PF, Hoofnagle JH, Park H, Mullen ED, Peters M, Jones B, Rustgi V, Jonas EA: Psychiatric complications of long-term interferon alpha therapy. Arch Intern Med 1987; 147:1577- 1580
  89. Stritz D, Valentine AD, Meyers CA: Manic episodes in two pa- tients treated with interferon alpha. J Neuropsychiatr Clin Neurosci 1997; 9:273-276
  90. Janssen HL, Brouwer JT, van der Mast RC, Schalm SW: Suicide associated with alfa-interferon therapy for chronic viral hep- atitis. J Hepatol 1994; 21:241-243
  91. Levenson J, Fallon HJ: Fluoxetine treatment of depression caused by interferon-alpha. Am J Gastroenterol 1993; 88: 760-761
  92. Denicoff KD, Rubinow DR, Papa MZ, Simpson C, Seipp CA, Lotze MT, Chang AE, Rosenstein D, Rosenberg SA: The neu- ropsychiatric effects of treatment with interleukin-2 and lym- phokine-activated killer cells. Ann Intern Med 1987; 107: 293-300
  93. Klingemann HG: Clinical applications of recombinant human colony stimulating factors. Can Med Assoc J 1989; 140:137-142
  94. Weinblatt ME, Kremer JM, Bankhurst AD, Bulpitt KJ, Fleisch- mann RM, Fox RI, Jackson CG, Lange M, Burge DJ: A trial of et- anercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiv- ing methotrexate. N Engl J Med 1999; 340:253-259
  95. Rogler G, Andus T: Cytokines in inflammatory bowel disease. World J Surg 1998; 22:382-389
  96. Norris JG, Benveniste EN: Interleukin-6 production by astro- cytes: induction by the neurotransmitter norepinephrine. J Neuroimmunol 1993; 45:137-146
  97. Schleuning MJ, Duggan A, Reem GH: Inhibition by chlorpro- mazine of lymphokine-specific m-RNA expression in human thymocytes. Eur J Immunol 1989; 19:1491-1496
  98. Bertini S, Garattini R, Delgado P, Ghezzi P: Pharmacological activities of chlorpromazine involved in the inhibition of tu- mor necrosis factor production in vivo in mice. Immunology 1993; 79:217-219
  99. Maes M, Meltzer HY, Bosmans E: Immune-inflammatory markers in schizophrenia: comparison to normal controls and effects of clozapine. Acta Psychiatr Scand 1994; 89:346-351
  100. Sperner-Unterweger B, Gaggl S, Fleischhacker WW, Barnas C, Herold M, Geissler D: Effects of clozapine on hematopoiesis and the cytokine system. Biol Psychiatry 1993; 34:536-543
  101. Song C, Leonard E: An acute phase protein response in the olfactory bulbectomised rat: effect of sertraline treatment. Med Sci Res 1994; 22:313-314
  102. Kronfol Z, LeMay L, Nair M, Kluger M: Electroconvulsive ther- apy increases plasma levels of interleukin-6. Ann NY Acad Sci 1990; 594:463-465